SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

Products > Clinical Study

Cholesterol support for low/med risk individuals

Published: 12-Oct-2015 | Format: PDF file | Document type: Clinical Study
Kyowa Hakko Clinical Study

Millions of health conscious consumers are looking for nutritional support to help maintain healthy cholesterol levels. With numerous studies supporting Pantesin’s effectiveness in high-risk subjects, current research shows that it is also effective for low to medium risk individuals. This positions Pantesin as a smart addition to a heart health program for anyone concerned with maintaining healthy blood lipid levels. Pantesin is also the only pantethine backed by more than 35 years of research for safety and efficacy.

LATEST CONTENT FROM Kyowa Hakko

Cognizin Citicoline: A brain health ingredient supported by clinical trial data

If the cognition market is to come to represent a proportion of the overall supplement market that is more indicative of the importance of brain health, ingredient suppliers must provide manufacturers with indisputable data demonstrating the efficacy of their products.

Pantesin® pantethine: Comprehensively aiding cardiovascular health for 40 years

Heart disease is a rare case of a big problem with a clear solution: Lower LDL. In Pantesin, manufacturers have an ingredient with a 40-year history of doing just that.

Supplier's Info Centre

Kyowa Hakko